Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002205624 | SCV002366720 | likely benign | Gastrointestinal stromal tumor; Paragangliomas 3 | 2024-09-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002361471 | SCV002666771 | likely benign | Hereditary cancer-predisposing syndrome | 2020-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Myriad Genetics, |
RCV005424719 | SCV006094161 | benign | Paragangliomas 3 | 2025-03-13 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |